Cantor Fitzgerald Believes Exponent (EXPO) Still Has Room to Grow

Cantor Fitzgerald analyst Joseph Foresi assigned a Buy rating to Exponent (NASDAQ: EXPO) today and set a price target of $96. The company’s shares closed on Friday at $94.15, close to its 52-week high of $94.70.

Foresi observed:

“Our Overweight rating on Exponent is based on our belief the nature of its business gives it an advantage in its ability to deliver results regardless of the economic backdrop. Exponent boasts excellent management with a solid history of performance and competitive advantages in industry expertise. We expect revenues to grow in the mid-to-high single-digit range in 2018, with the opportunity for upside, as we believe catalysts exist in a number of areas.”

According to TipRanks.com, Foresi is a top 25 analyst with an average return of 17.4% and a 83.8% success rate. Foresi covers the Technology sector, focusing on stocks such as Jack Henry & Associates, Fidelity National Info, and Exlservice Holdings.

Exponent has an analyst consensus of Moderate Buy, with a price target consensus of $95.50.

See today’s analyst top recommended stocks >>

Exponent’s market cap is currently $2.45B and has a P/E ratio of 56.72. The company has a Price to Book ratio of 7.98.

Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of solutions. It operates through two segments: Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment provides technical consulting in the areas of engineering and technology development.